Zalgen Labs
Medtech · Private
ELISA immunoassay measuring humoral response to Lassa virus glycoprotein for vaccine efficacy and therapeutic monitoring
zalgenlabs.com →- Grants
- $6.6M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $97K
- 7 awards · Health and Human S, State
- #531 of 4531 in medtech
- Patents
- 3
- 2 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnostics | $927,590 | |
| Federal grant | Department of Health and Human Services · Phase II · Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnostics | $1,856,094 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Evaluation of fully human Pan-Old World Arenavirus monoclonal antibodies as candidate therapeutics for LCMV infection | $147,718 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Evaluation of fully human Pan-Old World Arenavirus monoclonal antibodies as candidate therapeutics for LCMV infection | $147,718 | |
| Federal grant | Department of Health and Human Services · Phase II · Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnostics | $928,504 | |
| Federal grant | Department of Health and Human Services · Phase II · Recombinant antigen diagnostics for filoviruses | $1,000,000 | |
| Federal contract | Department of Health and Human Services · Relasv Pan-lassa G/m (10 Plate Bulk Elisa Kit), | $6,172 | |
| Federal contract | Department of Health and Human Services · Relasv Pan-lassa G/m (10 Plate Bulk Kit) | $6,200 | |
| Federal contract | Department of Health and Human Services · Zalgen Labs, Llc Relasv Pan-lassa G/m Gp (10 Plate Bulk Kit), | $6,135 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine | $497,084 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine | $796,134 | |
| Federal grant | Department of Health and Human Services · Phase I · Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine | $299,050 | |
| Federal contract | Department of Health and Human Services · Relasv Pan-lassa Np Elisa Kits Zalgen Labs | $30,940 | |
| Federal contract | Department of State · Conak, Cdc - Rapid Diagnostic Test Kits Lassa Fever | $12,520 | |
| Federal contract | Department of Health and Human Services · Re-lasv Pan-lassa Elisa Kits (ambis #2141841) | $14,900 | |
| Federal contract | Department of Health and Human Services · Pan-lassa Elisa Kits | $20,615 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 528 | CenTrak, Inc. | $98K | $832K |
| 529 | HIGHLAND INSTRUMENTS INC | $98K | $750K |
| 530 | New View Surgical, Inc. | $98K | $16M |
| 531 | Zalgen Labs | $97K | — |
| 532 | SONITUS MEDICAL INC | $97K | $58M |
| 533 | Golden Helix, Inc. | $93K | — |
| 534 | ZRT LABORATORY, LLC | $92K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Arenavirus Monoclonal Antibodies And Usesgranted
- Arenavirus Monoclonal Antibodies And Usesapplication
- Arenavirus Monoclonal Antibodies And Usesgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.